UG3NS132127
Cooperative Agreement
Overview
Grant Description
Single molecule detection of L1 insertions and intermediates.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
Massachusetts
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have decreased 2% from $900,930 to $878,434.
Dana-Farber Cancer Institute was awarded
Single molecule detection of L1 insertions and intermediates
Cooperative Agreement UG3NS132127
worth $878,434
from the National Institute of Allergy and Infectious Diseases in April 2023 with work to be completed primarily in Massachusetts United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 9/5/25
Period of Performance
4/1/23
Start Date
3/31/25
End Date
Funding Split
$878.4K
Federal Obligation
$0.0
Non-Federal Obligation
$878.4K
Total Obligated
Activity Timeline
Transaction History
Modifications to UG3NS132127
Additional Detail
Award ID FAIN
UG3NS132127
SAI Number
UG3NS132127-1269636882
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NQ00 NIH National Institute of Neurological Disorders and Stroke
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
DPMGH9MG1X67
Awardee CAGE
5E915
Performance District
MA-90
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $450,465 | 100% |
Modified: 9/5/25